Texas 2015 84th Regular

Texas House Bill HB1199 House Committee Report / Fiscal Note

Filed 02/02/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD    Austin, Texas      FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION            April 26, 2015      TO: Honorable René Oliveira, Chair, House Committee on Business & Industry      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:HB1199 by Simpson (Relating to deceptive representations or other conduct concerning certain synthetic substances as a violation of the Deceptive Trade Practices-Consumer Protection Act.), Committee Report 1st House, Substituted    No significant fiscal implication to the State is anticipated.  The bill would amend the Business and Commerce Code to make the sale of certain synthetic drugs a violation of the Deceptive Trade Practices-Consumer Protection Act.  The bill would take effect September 1, 2015.The Office of the Attorney General indicated the costs associated with implementation of the bill could be absorbed with existing resources. Local Government Impact No fiscal implication to units of local government is anticipated.    Source Agencies:302 Office of the Attorney General   LBB Staff:  UP, CL, TBo    

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION
April 26, 2015





  TO: Honorable René Oliveira, Chair, House Committee on Business & Industry      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:HB1199 by Simpson (Relating to deceptive representations or other conduct concerning certain synthetic substances as a violation of the Deceptive Trade Practices-Consumer Protection Act.), Committee Report 1st House, Substituted  

TO: Honorable René Oliveira, Chair, House Committee on Business & Industry
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: HB1199 by Simpson (Relating to deceptive representations or other conduct concerning certain synthetic substances as a violation of the Deceptive Trade Practices-Consumer Protection Act.), Committee Report 1st House, Substituted

 Honorable René Oliveira, Chair, House Committee on Business & Industry 

 Honorable René Oliveira, Chair, House Committee on Business & Industry 

 Ursula Parks, Director, Legislative Budget Board

 Ursula Parks, Director, Legislative Budget Board

HB1199 by Simpson (Relating to deceptive representations or other conduct concerning certain synthetic substances as a violation of the Deceptive Trade Practices-Consumer Protection Act.), Committee Report 1st House, Substituted

HB1199 by Simpson (Relating to deceptive representations or other conduct concerning certain synthetic substances as a violation of the Deceptive Trade Practices-Consumer Protection Act.), Committee Report 1st House, Substituted



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.



The bill would amend the Business and Commerce Code to make the sale of certain synthetic drugs a violation of the Deceptive Trade Practices-Consumer Protection Act.  The bill would take effect September 1, 2015.The Office of the Attorney General indicated the costs associated with implementation of the bill could be absorbed with existing resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies: 302 Office of the Attorney General

302 Office of the Attorney General

LBB Staff: UP, CL, TBo

 UP, CL, TBo